Title: Corporate Governance Mechanisms And Accounting Disclosure Of Quoted Pharmaceutical Companies In Nigeria
Authors: Dr Henry O. Wobo, SAM, LAWYER OGWE
Volume: 8
Issue: 11
Pages: 81-91
Publication Date: 2024/11/28
Abstract:
The study investigated the relationship between corporate governance mechanisms and accounting disclosures of quoted pharmaceutical companies in Nigeria between the periods of 2013 to 2022, and to determine whether there is a significant relationship among the measures of corporate governance mechanisms and accounting disclosure. The study adopted both quantitative and ex-post-facto research designs, while the purposive sampling technique was used to choose seven (7) quoted pharmaceutical companies that merit the requirements of the study. The method of data collection was secondary data collection, and the econometric approach of Ordinary Least Square (OLS) analysis technique was used to test the level of relationship between the independent and dependent variables and the level of significance in relationships between the variables. The result of the analyses showed that some corporate governance mechanisms such as Board Independence (BIND), Board Sizes (BSZ) and Board Diversity (BDVER) have negative relationships with the Accounting Disclosure (ACD). From the findings, the study concluded that there is no evidence to show that the presence of board independence, board size and board diversity have any effect on the accounting disclosure levels of quoted pharmaceutical firms in Nigeria. The study therefore recommended that publicly quoted pharmaceutical companies, through regulatory authorities, should increase the number of Independent Directors in the Board, Board size and Board diversity in order to increase its positive effects on accounting disclosure.